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Abstract
Background: Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a key transcription factor regulating a plethora of
detoxifying enzymes and antioxidant genes involved in drug metabolism and defence against oxidative stress. The
glucocorticoid receptor (GR) is a ligand-induced transcription factor involved in the regulation of energy supply for
metabolic needs to cope with various stressors. GR activity is controlled by glucocorticoids, which are synthesized in the
adrenal glands and regenerated mainly in the liver from inactive cortisone by 11b-hydroxysteroid dehydrogenase-1 (11b-
HSD1).
Methods and Principal Findings: Using transfected HEK-293 cells and hepatic H4IIE cells we show that glucocorticoids,
activated by 11b-HSD1 and acting through GR, suppress the Nrf2-dependent antioxidant response. The expression of the
marker genes NQO1, HMOX1 and GST2A was suppressed upon treatment of 11b-HSD1 expressing cells with cortisone, an
effect that was reversed by 11b-HSD1 inhibitors. Furthermore, our results demonstrate that elevated glucocorticoids
lowered the ability of cells to detoxify H2O2. Moreover, a comparison of gene expression in male and female rats revealed an
opposite sexual dimorphism with an inverse relationship between 11b-HSD1 and Nrf2 target gene expression.
Conclusions: The results demonstrate a suppression of the cellular antioxidant defence capacity by glucocorticoids and
suggest that elevated 11b-HSD1 activity may lead to impaired Nrf2-dependent antioxidant response. The gender-specific
differences in hepatic expression levels of 11b-HSD1 and Nrf2 target genes and the impact of pharmacological inhibition of
11b-HSD1 on improving cellular capacity to cope with oxidative stress warrants further studies in vivo.
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Introduction
The liver is metabolically highly active, essentially regulating
carbohydrate and lipid metabolism as well as the detoxification of
xenobiotics and reactive endogenous chemicals. Various cytopro-
tective genes, including those under the control of the transcription
factor nuclear factor (erythroid 2)-like 2 (Nrf2, NFE2L2 gene), are
expressed in hepatocytes to avoid cellular damage by reactive
compounds. Nrf2 is the key player of the tightly regulated
antioxidant cell defense system [1]. Upon recognition of the
antioxidant responsive elements (ARE) on the promoters of its
target genes, Nrf2 modulates basal and ligand-induced expression
of various cytoprotective enzymes [2]. The importance of Nrf2 is
shown in knockout mice, exhibiting an enhanced susceptibility
towards oxidative stress caused by xenobiotics due to diminished
expression of cytoprotective genes [3,4,5,6]. Nrf2 target genes
include essential phase II detoxification enzymes such as
NAD(P)H:quinone oxidoreductases (NQO) [7], heme oxygenase-
1 (HO-1, HMOX1 gene) [8] and glutathione S-transferases (GST)
[1,9] that are induced by oxidative stress caused by xenobiotics,
antioxidants, UV-light, and ionizing radiation [2].
A recent study reported gender-divergent expression of NQO1
in specific rat strains studied [10]. Hepatic basal NQO1 mRNA
expression was two-fold lower in male compared with female
Sprague Dawley rats. Induction of NQO1 expression with the
classical Nrf2 inducers butylated hydroxyanisole and oltipraz was
more pronounced in female compared with male rats. Important-
ly, it has been reported that male rats have higher susceptibility to
carcinogenic xenobiotics [11]. Interestingly, gender-related differ-
ences were also found for humans [12]; however, the underlying
mechanisms remain unknown.
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Decreased Nrf2-mediated constitutive and oltipraz- or tert-
butylhydroquinone (t-BHQ)-inducible GSTA2 gene expression was
found in rat H4IIE hepatoma cells upon activation of the
glucocorticoid receptor (GR) by dexamethasone [13]. Importantly,
the oxidized metabolite of dexamethasone, 11-ketodexametha-
sone, is also a potent GR agonist; thereby dexamethasone
circumvents the 11b-hydroxysteroid dehydrogenase (11b-HSD)
mediated control of GR activation [14]. Under physiological
conditions, hepatic GR function depends on the circulating
concentration of glucocorticoids produced by the adrenal glands
and on the activity of hepatic 11b-HSD1, which converts the
inactive 11-ketoglucocorticoids cortisone and 11-dehydrocorticos-
terone into their active 11b-hydroxyls cortisol and corticosterone
[15]. In mice, the transgenic over expression of 11b-HSD1
specifically in the liver resulted in the development of impaired
insulin sensitivity and steatosis, demonstrating the adverse
metabolic effects of elevated hepatic glucocorticoid activation [16].
The impact of endogenous glucocorticoids and of 11b-HSD1 on
the antioxidant redox pathway has not yet been studied.
Therefore, we used rat H4IIE cells, known to express functional
Nrf2 and down-stream regulated enzymes [13,17,18], and H4IIE
cells transiently or stably transfected with 11b-HSD1 to elucidate
its impact on the antioxidant response pathway. Moreover, we
studied whether the observed gender differences in hepatic 11b-
HSD1 expression in rats [19,20] may correlate with differences in
the expression of Nrf2 target genes.
Results
Glucocorticoid-mediated inhibition of Nrf2-dependent
transactivation in HEK-293 cells
To assess whether glucocorticoids inhibit Nrf2 function, we
transiently expressed Nrf2 and GR together with the ARE8L-
luciferase reporter [21] in HEK-293 cells (Fig. 1). Incubation of
the cells with 10 mM sulforaphane for 24 h resulted in three- to
four-fold increased ARE8L-reporter activity. Activation of GR by
simultaneous incubation with the active glucocorticoid cortisol
within physiological concentrations (100 nM) for 24 h suppressed
Nrf2-dependent transactivation (Fig. 1A). Cortisone, the physio-
logically inactive form, requires prior activation to cortisol by an
enzymatic tissue-specific process catalyzed by 11ß-HSD1. Corti-
sone in the absence of 11b-HSD1 did not affect sulforaphane-
induced reporter gene activation (Fig. 1B) but suppressed reporter
gene activation in cells expressing 11b-HSD1, an effect that was
fully reversed by the selective 11b-HSD1 inhibitor T0504 (Fig. 1C).
The GR antagonist RU-486 also fully restored Nrf2-mediated
transactivation. No inhibition of recombinant human 11b-HSD1
(measured using cell lysates) was observed at 2 mM; at 20 mM
a weak inhibition with 6968% remaining activity was obtained
(data not shown).
Induction of the Nrf2-dependent ARE8L-reporter in rat
H4IIE hepatoma cells
Next, we characterized the responsiveness of the Nrf2 pathway
in H4IIE cells transiently transfected with the ARE8L-reporter. As
shown in Figure 2A, 10 mM sulforaphane stimulated ARE8L-
reporter activity approximately seven-fold. Co-transfection of the
cells with recombinant Nrf2 further stimulated ARE8L-reporter
activity almost two-fold. It was reported that Nrf2 protein has
a short half-life (of about 15 min), which is significantly enhanced
by proteasome inhibitors [22]. Upon incubation of H4IIE cells
with the proteasome inhibitor MG132 we observed approximately
two-fold increased protein levels of Nrf2 and its target NQO1 (Fig.
S1). We then assessed ARE8L-reporter activity in cells treated with
sulforaphane and the proteasome inhibitor MG132 (10 mM).
Total luciferase reporter activity was two to three times higher in
the presence of the proteasome inhibitor.
Currently, there are no hepatocellular lines available that
express substantial levels of 11b-HSD1. We found that the rat
hepatoma HPCT-1E3 cell line [23] expresses low to moderate
levels of endogenous 11b-HSD1. However, HPCT-1E3 cells need
to be cultivated in the presence of 1.5 mM of the potent
glucocorticoid dexamethasone, which makes it a model with
limited use to study interactions between glucocorticoids and
antioxidant redox pathway. Moreover, although primary hepato-
cytes express high levels of 11b-HSD1, expression levels rapidly
decline upon cultivation, resulting in large inter-experimental
differences. Therefore, we recently constructed a H4IIE cell clone
stably expressing 11b-HSD1 (designated as H4H1) [24]. The 11b-
HSD1 cortisone reductase activity of H4H1 cells is comparable
with that of freshly isolated primary hepatocytes but more than ten
times higher than that of HPCT-1E3 cells. The Nrf2-dependent
ARE8L-reporter was activated in H4H1 cells by sulforaphane
both in the presence or absence of co-transfected recombinant
Nrf2 (Fig. 2B).
11b-HSD1-mediated glucocorticoid activation suppresses
Nrf2 transactivation capacity
The observation that over expression and activation of GR in
HEK-293 cells inhibits Nrf2-dependent transactivation of the
ARE8L-reporter led us to investigate the impact of 11b-HSD1
and glucocorticoids on Nrf2 transactivation in cells expressing
endogenous Nrf2 levels. In H4IIE cells expressing endogenous
Nrf2, the effective concentration of cortisol leading to a 50%
down-regulation of the sulforaphane-induced Nrf2 transactivation
capacity was determined to be 1065 nM (Fig. 2C). In further
experiments, incubation of H4IIE cells with 100 nM cortisol
almost completely abolished sulforaphane-induced ARE8L-re-
porter activation. Neither cortisone nor T0504 affected Nrf2-
dependent transactivation (Fig. 2D). H4IIE cells are devoid of
endogenous 11b-HSD1 expression, as measured by real-time RT-
PCR (not shown); therefore, we transiently transfected H4IIE cells
with rat 11b-HSD1 and found diminished Nrf2 activity upon
addition of cortisol or cortisone (Fig. 2E).
11b-HSD1 inhibitors and GR antagonists reverse
glucocorticoid-mediated suppression of Nrf2
transactivation
Suppression of Nrf2 transactivation by cortisone in 11b-HSD1
expressing H4IIE cells was fully reversed by 1 mM of the selective
11b-HSD1 inhibitor T0504 (Fig. 2E). To ensure that the observed
effects are not due to sulforaphane-dependent 11b-HSD1 in-
hibition, we measured 11b-HSD1-mediated conversion of corti-
sone to cortisol in H4H1 cells. Sulforaphane did not affect 11b-
HSD1 enzyme activity (Fig. S2). To overcome experimental
differences due to transfection efficiency, we studied the impact of
11b-HSD1 inhibition on Nrf2-dependent transactivation in H4H1
cells (Fig. 2F). Incubation with 10 mM sulforaphane for 24 h
resulted in an eight-fold activation of the ARE8L-reporter.
ARE8L-reporter activity in H4H1 cells treated with sulforaphane
was not significantly altered by the addition of T0504. Impor-
tantly, following 24 h incubation of H4H1 cells with 100 nM
cortisone and 10 mM sulforaphane, Nrf2-dependent activation of
the ARE8L-reporter was significantly decreased, and reporter
activity was indistinguishable from that of DMSO treated cells.
The suppression of Nrf2 function due to 11b-HSD1 activity was
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almost fully reversed by the 11b-HSD1 inhibitor T0504 or the GR
antagonist RU-486.
Oxidative stress induced by H2O2 enhances Nrf2-
dependent pathway but not 11b-HSD1 expression and
GR activity
We tested whether H2O2 might affect 11b-HSD1 activity or
GR-dependent transactivation. H2O2 did not affect 11b-HSD1
activity and GR transactivation at subcytotoxic concentrations (up
to 5 mM) in HEK-293 cells (data not shown). H4IIE, H4H1 and
HPCT-1E3 cells have a much higher ability to cope with H2O2
and concentrations up to 2 mM did not cause overt cytotoxic
effects. Incubation of H4H1 and HPCT-1E3 cells for 24 h in the
presence of 2 mM H2O2 did not alter 11b-HSD1 mRNA
expression and cortisone reductase activity (not shown and Fig.
S3). To assess whether H2O2 influences the GR pathway we
assessed the transcriptional activity of the GR by employing
a TAT3-TATA reporter gene in H4IIE cells (Fig. 3A). Cells were
incubated with cortisol (100 nM) with or without H2O2 (2 mM)
for 24 h. Cortisol treatment resulted in 20-fold increased TAT3-
TATA-reporter activity and the reporter response was indistin-
guishable from cells treated simultaneously with cortisol and
H2O2.
In contrast, oxidative stress increased Nrf2-dependent antiox-
idant response. We investigated whether H2O2 induces ARE8L
reporter activity in H4IIE cells stably expressing this reporter
(designated as ARECS3 clone). ARECS3 cells were treated with
vehicle (0.05% DMSO) or sulforaphane (10 mM) in the presence
or absence of H2O2 (2 mM). H2O2-induced oxidative stress
increased both basal as well as sulforaphane-induced activity of the
ARE8L reporter (Fig. 3B). In addition, H2O2 enhanced basal as
well as sulforaphane-induced NQO1 mRNA in H4IIE cells
treated with vehicle (0.05% DMSO) or sulforaphane (10 mM)
(Fig. 3C).
Downregulation of NQO1 and GST2A mRNA expression
by cortisol in H4IIE cells
Next, we determined the expression of NQO1 and GSTA2
mRNA in H4IIE cells treated with sulforaphane in the absence or
presence of glucocorticoids. Treatment with sulforaphane en-
hanced NQO1 and GSTA2 mRNA expression approximately 2.5-
and 3.5-fold, respectively, compared with DMSO treated controls.
Co-incubation of H4IIE cells with sulforaphane and 100 nM
cortisol resulted in significantly lower NQO1 and GSTA2 mRNA
expression, whereas cortisone in the absence of 11b-HSD1 was
ineffective (Fig. 4).
Cortisol suppresses NQO1 and Nrf2 protein levels
induced by H2O2 in H4IIE cells
To further support the impact of glucocorticoids on Nrf2
transcriptional activity and protein expression, we induced
oxidative stress by incubating H4IIE cells with H2O2 and
determined the suppressive effect of cortisol on Nrf2 and NQO1
protein levels. Cells were treated with vehicle (0.05% DMSO),
cortisol (100 nM), sulforaphane (10 mM) or combinations of them,
in the presence or absence of H2O2 (2 mM), followed by
measurement of Nrf2 and NQO1 protein levels by Western blot
analysis. H2O2 increased both basal and sulforaphane-induced
Nrf2 and NQO1 protein. Cortisol treated cells showed reduced
H2O2- and sulforaphane-inducible NQO1 and Nrf2 protein
Figure 1. Suppression of Nrf2-dependent reporter gene activation by glucocorticoids in HEK-293 cells. HEK-293 cells transiently
transfected with plasmids for Nrf2, GR, ARE8L-reporter, pCMV-LacZ and either pcDNA3 (A, B) or 11b-HSD1 (C) were incubated for 24 h with vehicle
(DMSO), 10 mM sulforaphane, 100 nM cortisone or cortisol, in the presence or absence of 1 mM T0504 or RU-486. Data (mean 6 SD) were obtained
from three independent experiments each measured in triplicate. *, p,0.05, **, p,0.01, ***, p,0.001, p-value was obtained using one-way ANOVA
followed by Bonferroni post-tests compared with vehicle control (DMSO).
doi:10.1371/journal.pone.0036774.g001
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Figure 2. Suppression of Nrf2 transactivation by 11b-HSD1-mediated glucocorticoid activation in H4IIE cells. The activation of the
Nrf2-dependent ARE8L-reporter by 10 mM sulforaphane was measured in rat H4IIE hepatoma cells (A) and in H4IIE cells stably expressing 11b-HSD1
(H4H1 clone) (B) at endogenous Nrf2 expression (black bars) and upon over expression of Nrf2 (white bars). CMV-LacZ plasmid served as a transfection
control to normalize luciferase values. Cells were treated with vehicle (DMSO), sulforaphane (10 mM), or sulforaphane and proteasome inhibitor
MG132 (10 mM) for 24 h. H4IIE cells transfected with ARE8L-reporter and pCMV-LacZ cells were incubated with sulforaphane and increasing
concentrations of glucocorticoids for 24 h, followed by measuring luciferase activity to estimate the effective concentration of cortisol leading to
a 50% reduction of the reporter activity (C). Suppression of Nrf2 transactivation by glucocorticoids was further studied in H4IIE cells transiently
transfected with ARE8L-reporter and pcDNA3 (D) or with ARE8L-reporter and 11b-HSD1 (E). Cells were incubated with vehicle or sulforaphane,
glucocorticoids and vehicle or 11b-HSD1 inhibitor T0504 at the concentrations indicated for 24 h, followed by measuring luciferase activity. The
impact of 11b-HSD1 inhibitors and GR antagonists on Nrf2-dependent transactivation was similarly assessed in H4H1 cells transfected with ARE8L-
reporter and pCMV-LacZ (F). Data represent mean 6 SD from at least two independent experiments performed in triplicate. *, p,0.05, **, p,0.01,
***, p,0.001, p-value was obtained using one-way ANOVA followed by Bonferroni post-tests compared with control (DMSO), ns, not significant.
doi:10.1371/journal.pone.0036774.g002
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Figure 3. Influence of oxidative stress on Nrf2 pathway and GR transactivation. The activation of the GR-dependent TAT3-TATA-reporter
by 100 mM cortisol was measured in rat H4IIE hepatoma cells with endogenous GR expression (A). CMV-LacZ plasmid served as transfection control to
normalize luciferase values. Cells were treated with vehicle (DMSO) or cortisol (100 mM), with or without H2O2 (2 mM) for 24 h at 37uC. Data represent
mean 6 SD from at least three independent experiments performed in triplicate. The influence of oxidative stress induced by H2O2 on Nrf2-
dependent transactivation was measured in ARECS3 cells stably expressing the ARE8L-reporter (B). Cells were treated with vehicle (DMSO) or
sulforaphane (10 mM) in the presence or absence of H2O2 (2 mM) for 24 h. Data represent mean 6 SD from three independent experiments
measured in triplicate. Activation of NQO1 mRNA expression by H2O2 was measured in H4IIE cells (C). Cells were incubated for 24 h at 37uC with
vehicle (0.05% DMSO) or sulforaphane (10 mM) in the presence or absence of H2O2 (2 mM), followed by determination of NQO1 mRNA levels by real-
time RT-PCR. Data (mean 6 SD from two independent experiments measured in triplicate) represent ratios of NQO1 mRNA to GAPDH control mRNA
from treated cells normalized to the values obtained from cells incubated with vehicle (DMSO).
doi:10.1371/journal.pone.0036774.g003
Figure 4. Inhibition of Nrf2-induced mRNA expression of NQO1 and GSTA2 by cortisol. H4IIE cells were incubated for 24 h at 37uC with
10 mM sulforaphane in the absence or presence of 100 nM cortisol or cortisone, respectively, followed by determination of NQO1 (A) and GSTA2
mRNA levels (B) by real-time RT-PCR. Data (mean 6 S.D. from three independent experiments performed in triplicate) represent ratios of NQO1 and
GSTA2 mRNA to GAPDH control mRNA from treated cells normalized to the values obtained from cells incubated with vehicle (DMSO). *, p,0.05, **,
p,0.01, ***, p,0.001, p-values were obtained using one-way ANOVA followed by Bonferroni post-tests compared with vehicle control (DMSO).
doi:10.1371/journal.pone.0036774.g004
Suppression of Nrf2 Response by Glucocorticoids
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Figure 5. Suppression of Nrf2 and NQO1 protein expression by cortisol in oxidative stress-induced H4IIE cells. H4IIE cells were treated
for 24 h with vehicle (DMSO), cortisone, sulforaphane or cortisone and sulforaphane in the presence or absence of H2O2. Cells were lysed, and equal
protein amounts were used for Western blot analysis. Samples were probed for Nrf2 and NQO1 using actin as a loading control. The lower panel
shows a densitometric analysis of Nrf2 (left) and NQO1 (right) protein normalized against b-actin. A representative experiment is shown.
doi:10.1371/journal.pone.0036774.g005
Suppression of Nrf2 Response by Glucocorticoids
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expression upon co-incubation with cortisol compared with cells
treated with sulforaphane or H2O2 alone (Fig. 5).
Downregulation of NQO1 protein levels in H4IIE cells
expressing 11b-HSD1
To further support the suppressive effect of glucocorticoids on
Nrf2 activity, we determined NQO1 protein levels in H4IIE cells
transfected with either an empty vector (pcDNA3) or 11b-HSD1
expression plasmid. Cells were treated with vehicle (0.05%
DMSO), cortisone (100 nM), sulforaphane (4 mM) or cortisone
and sulforaphane, followed by measurement of NQO1 protein by
Western blot analysis. In pcDNA3 transfected cells sulforaphane
treatment enhanced NQO1 protein expression, whereas cortisone
was ineffective (Fig. 6). Furthermore, cortisone alone did not affect
basal protein expression. In contrast, 11b-HSD1 transfected cells
showed reduced sulforaphane inducible NQO1 protein expression
upon co-incubation with sulforaphane and 100 nM cortisone
compared with cells treated with sulforaphane alone.
Inhibition of 11b-HSD1 restores sulforaphane-induced
NQO1 and GST2A mRNA expression in H4H1 cells
Next, we investigated the impact of 11b-HSD1 activity on
NQO1 mRNA expression in H4H1 cells (Fig. 7). Treatment with
sulforaphane enhanced NQO1 mRNA expression, an effect which
was significantly reduced upon simultaneous incubation of cells
with sulforaphane and 100 nM cortisone. Similar observations
were made for GST2A mRNA expression (Fig. S4). Treatment
with cortisone suppressed basal expression of NQO1 and GST2A.
In contrast, simultaneous incubation with cortisone and 1 mM of
the 11b-HSD inhibitor glycyrrhetinic acid (GA) (Fig. 7), or the
structurally unrelated 11b-HSD1 inhibitor T0504 (Fig. S4),
showed no significant effect on basal or sulforaphane-induced
NQO1 mRNA expression but completely reversed the suppressive
effect by cortisone. Experiments with HPCT-1E3 cells with
endogenous 11b-HSD1 confirmed the suppression of NQO1
and GST2A mRNA expression upon incubation with cortisone
(Fig. S5).
Impact of glucocorticoids on the susceptibility to H2O2
To test the antioxidant response, we studied the sensitivity of
H4IIE cells to H2O2. Accordingly, H4IIE cells were transiently
transfected with a plasmid for the cytosolic H2O2-sensor HyPer
and an empty expression vector (pCDNA3). Cells were treated
with 100 nM cortisol for 24 h followed by treatment with H2O2
(100 mM) and real-time measurements of the HyPer response to
the resulting cytosolic H2O2 concentration (Fig. 8A). H4IIE
treated with cortisol showed an enhanced response to H2O2
compared with vehicle treated cells. Next, H4IIE cells were
transiently transfected with plasmids for the cytosolic H2O2-sensor
HyPer and either 11b-HSD1 or empty vector. Cells were treated
with 100 nM cortisone for 24 h. The real-time measurements of
the HyPer response to the cytosolic H2O2 concentration in empty
vector control cells showed a rapid increase upon addition of
10 mM H2O2 (Fig. 8B). The initial peak was followed by a gradual
decrease, reaching about 50% of the peak value after a recovery
period of 25 min. In contrast, H4IIE transiently transfected with
Figure 6. Suppression of NQO1 protein expression by corti-
sone in 11b-HSD1 expressing H4IIE cells but not in pCDNA3
transfected cells. H4IIE cells transiently transfected with either
pCDNA3 or 11b-HSD1 were treated for 24 h with vehicle (DMSO),
cortisone, sulforaphane or cortisone and sulforaphane (upper panel).
Cells were lysed, and equal protein amounts were used for Western blot
analysis. Samples were probed for NQO1 using actin as a loading
control. Lower panel, densitometric analysis of NQO1 bands normalized
against b-actin. Graphs are representative of three independent
experiments.
doi:10.1371/journal.pone.0036774.g006
Figure 7. 11b-HSD1-mediated suppression of Nrf2-induced
NQO1 expression in H4H1 cells. H4H1 cells were incubated for 24 h
at 37uC with 10 mM sulforaphane in the absence or presence of 100 nM
cortisone and 1 mM glycyrrhetinic acid (GA), followed by quantification
of mRNA levels by real-time RT-PCR. Data (mean 6 S.D. from three
independent experiments performed in triplicate) represent ratios of
NQO1 mRNA to GAPDH control mRNA from treated cells normalized to
the values obtained from cells incubated vehicle (DMSO). *, p,0.05, **,
p,0.01, ***, p,0.001, p-values were obtained using one-way ANOVA
followed by Bonferroni post-tests compared with vehicle control
(DMSO).
doi:10.1371/journal.pone.0036774.g007
Suppression of Nrf2 Response by Glucocorticoids
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11b-HSD1 showed an enhanced response to H2O2. Furthermore,
25 min after H2O2 injection, the HyPer fluorescence ratio was
only marginally reduced, indicating an impaired ability to
eliminate H2O2 in 11b-HSD1 expressing H4IIE cells. Simulta-
neous treatment with T0504 partially restored the cellular
recovery from the H2O2 challenge (about 70% of the peak value
after 25 min). Also, there was a tendency of lower peak response.
Thus, the changes observed upon 11b-HSD1 expression were
likely due to 11b-HSD1-mediated cortisol generation.
To more clearly visualize the observed differences upon 11b-
HSD1 transfection, we performed a similar experiment using
higher H2O2 concentration (Fig. 8C). H4IIE cells transfected with
pCDNA3 or 11b-HSD1 were treated with cortisone, subjected to
live microscopy, and challenged with 100 mM H2O2. As expected,
the H2O2-induced increase in the HyPer fluorescence ratio was
more rapid, and the inhibitory effect of 11b-HSD1 on the
detoxification was more pronounced than in the experiment using
10 mM H2O2. Furthermore, while the signal reached almost
baseline levels in control cells after 40 min of recovery, it was only
slightly reduced in 11b-HSD1 expressing cells over the same time
frame.
Next, we assessed the impact of 11b-HSD1 on the response of
HyPer after a challenge with 100 mM H2O2 in a large cell
population using fluorescence spectrophotometry (Fig. 8D). 11b-
HSD1 expressing cells showed a more pronounced response to
H2O2 and even after 9 h the HyPer signal did not return to
baseline. Inhibition of 11b-HSD1 fully reversed this effect.
Rat genome chip analysis
Gender-specific differences in the expression of 11b-HSD1 and
the Nrf2 target NQO1 have been reported [10,19,20]. Higher
levels of 11b-HSD1 and lower levels of NQO1 have been observed
in male compared with female rats. However, the expression
analyses of 11b-HSD1 and NQO1 were performed independently
and in different rat strains. Therefore, we examined whether there
is an association between gender-specific 11b-HSD1 expression
and Nrf2 target gene expression in the same strain of rat. RNA
purified from whole liver tissues of ten male and ten female Han
Wistar rats were hybridized to Rat Genome 230 2.0 Affymetrix
chips (Table S1), and the analysis was restricted to a specific list of
genes (Table S2). The full chip data analysis will be released
elsewhere. In agreement with previous reports [19,20], 11b-HSD1
expression was significantly higher (10.7-fold) in male compared
with female rats (Fig. 9, for scatter plot see Fig. S6). Furthermore,
we observed ten-fold higher 11b-HSD1 activity in whole liver
homogenates of male compared with female rats. The elevated
ability to generate active glucocorticoids correlated with a signif-
icantly lower (2.1-fold) NQO1 mRNA expression. Additionally,
the Nrf2 target genes HMOX1 (1.4-fold) and ABCC3 (2.2-fold) were
also significantly down regulated in male compared with female
rats. Whereas the gender-specific differences in 11b-HSD1
expression levels correlated with differences in the basal expression
of the Nrf2-dependent target genes, the mRNA levels of the genes
encoding Nrf2 and GR did not differ between male and female
rats.
Discussion
To cope with the burden of reactive chemicals, sophisticated
defense mechanisms emerged during evolution. Nrf2 plays a key
role in regulating cellular responses to oxidative stress. Deficient or
impaired Nrf2 function has been closely related with several major
diseases such as rheumatoid arthritis [25,26], diabetes [27,28],
Parkinson’s [29] and various forms of cancer [30,31]. Despite the
Figure 8. Increased susceptibility of 11b-HSD1 expressing cells
to H2O2-induced oxidative stress. H4IIE cells transiently transfected
with pCDNA3 (A), pCDNA3 or 11b-HSD1 (B, C and D) were treated for
24 h with vehicle, 100 nM cortisol (A), 100 nM cortisone (C) or
simultaneously with cortisone and 1 mM T0504 (B, D). The medium
was replaced by assay buffer (HBSS) containing 1 g/L glucose. Single
cell real-time measurements were performed on a Leica SP5 confocal
microscope. After 5 min baseline adaption, cells were exposed to a final
concentration of 10 mM (A, B) or 100 mM (C, D) H2O2 and responses
were compared between differentially transfected or vehicle treated
cells over a period of 30 min (A, B) or 45 min (C). Data represent mean
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key role of Nrf2 in redox regulation, its mechanism of action is
highly complex and not fully understood [1,17].
Another transcription factor, playing a key role in the regulation
of many genes involved in biotransformation reactions and in the
adaptation to altered energy demand, is the GR. Most of the
reported studies addressing the impact of glucocorticoids on
detoxification reactions used dexamethasone. However, dexa-
methasone is a highly potent synthetic glucocorticoid with clearly
distinct properties compared with the endogenous glucocorticoid
cortisol. Dexamethasone, an approximately ten-times more potent
GR agonist than cortisol, activates also PXR at high concentra-
tions [32]. PXR and its co-receptor retinoid-X receptor (RXR) are
involved in the detoxification of xenobiotics by regulating the
expression of phase I (CYP3A4) and phase II enzymes [32]. Some
of the phase II enzymes regulated by Nrf2, including NQO1,
contain both XRE and ARE motifs in their promoter regions [33].
PXR-mediated transcriptional regulation of GSTA2 by high
concentrations of dexamethasone has been reported [34,35].
Therefore, it is important to distinguish between effects of
synthetic and endogenous glucocorticoids.
Since dexamethasone is not efficiently converted to 11-
ketodexamethasone and the oxidized metabolite 11-ketodexa-
methasone still is a potent GR agonist [14], dexamethasone
circumvents the important interconversion by 11b-HSD enzymes.
Endogenous glucocorticoids can be metabolically inactivated by
11b-HSD2 in tissues such as kidney and colon and regenerated by
11b-HSD1 mainly in the liver. 11b-HSD1 activity depends on the
availability of NADPH in the ER, which is determined by glucose-
6-phosphate supply and the activity of the ER luminal enzyme
H6PDH [36,37,38,39].
A possible mechanism for the suppression of the Nrf2 pathway
by the activated GR was proposed by Ki et al. [13]. GR activation
by dexamethasone and its subsequent binding to glucocorticoid
response elements (GRE) on the promoter of its target genes lead
to the recruitment of transcription factors such as silencing
mediator for retinoid and thyroid hormone receptors (SMRT) and
nuclear receptor corepressor (NCoR). In this model, recruited
SMRT acts as a corepressor by modulating chromatin structures
by histone deacetylation. SMRT was further found to directly bind
the Neh 4/5 domain of Nrf2, a protein motif essential for Nrf2
transactivation. The binding of SMRT to Neh 4/5 may then lead
to the repression of Nrf2 target genes.
Here, we demonstrate that cortisol, and cortisone following
conversion to cortisol by 11b-HSD1, suppress the Nrf2-dependent
antioxidant cell defense pathway. The cortisone and cortisol
concentrations used are in the physiological range, i.e. 100 nM.
Under physiological conditions, glucocorticoid concentrations
vary during circadian and ultradian rhythms, and it will be
important to investigate in future studies the impact of glucocor-
ticoid fluctuations on the Nrf2-dependent pathway in vivo. The
effect of glucocorticoids on Nrf2 activity is expected to be highly
tissue- and cell-specific, reflecting the expression of the respective
11b-HSD enzyme. Using H4IIE cells, we show that in the absence
of 11b-HSD1, cortisol (with an IC50 of 1065 nM) but not
cortisone suppresses Nrf2 activity (Fig. 2, 4 and 6). In tissues
expressing 11b-HSD2 (placenta, renal cortical collecting ducts,
distal colon, several cancer cells) Nrf2 may be rather insensitive to
glucocorticoids, which is in clear contrast to tissues expressing 11b-
HSD1 (liver, adipose, hippocampal neurons, macrophages) that
are able to generate active cortisol and are therefore exposed to
higher concentrations of active glucocorticoids.
A recent study reported elevated hepatic 11b-HSD1 expression
in patients with alcoholic liver disease (ALD) [40]. ALD-associated
disorders include fatty liver, inflammation, and hepatocellular
carcinoma in patients with liver cirrhosis [41]. Nrf2 prevents
ethanol-induced liver injury by induction of the detoxification of
acetaldehyde and inhibition of metabolite accumulation. Nrf2
knockout mice showed a dramatic increase in mortality following
feeding with ethanol doses which were well tolerated in wild-type
mice [42]. On a basic cellular level, our results suggest that
pharmacological inhibition of 11b-HSD1 and antagonism of GR
activity may be beneficial to restore the capacity of detoxification
processes regulated by Nrf2. This was supported by transactivation
assays, NQO1 mRNA expression levels (Fig. 2 and 7), and by the
use of the intracellular redox-sensor HyPer reflecting the activity of
Prx and HO-1 after H2O2 challenge (Fig. 8). In case of ALD, the
authors claimed that 11b-HSD1 inhibition may represent a novel
therapeutic approach to treat alcoholic pseudo-Cushing’s [40]. We
hypothesize that pharmacological inhibition of 11b-HSD1 may be
beneficial for restoring hepatic detoxification capacity, at least in
patients with ALD, which warrants clinical investigation.
In conclusion, the present study revealed a modulation of the
Nrf2-dependent regulation of the antioxidant response pathway by
glucocorticoids in hepatic H4IIE cells and suggests that elevated
11b-HSD1 activity may lead to impaired Nrf2-dependent cell
defence. The physiological effects of endogenous glucocorticoids
on the Nrf2-dependent detoxification may represent a novel fine-
tuning mechanism by which glucocorticoids regulate the balance
between energy supply, cell defense and ultimately cellular
homeostasis. Inhibition of 11b-HSD1 and antagonism of GR
restored the suppressive effect of elevated glucocorticoids on Nrf2-
6 SEM of seven different cells for each transfection. *, p,0.05, **,
p,0.01, ***, p,0.001, p-value was obtained using one-way ANOVA
followed by Bonferroni post-tests compared with pcDNA3 transfected
cells. To analyze the total cell population (D), H4IIE cells 4,000,000 cells/
mL were resuspended in assay buffer. Suspensions of cells (100 mL)
treated either with cortisone or cortisone and T0504 were transferred
into a 96-well plate, centrifuged for 2 min at 1806g and challenged by
adding 100 mL assay buffer containing 100 mM H2O2. Fluorescence was
immediately measured after adding H2O2 and data were collected every
27 s at 37uC for 9 h. One of three representative experiments is shown
(D).
doi:10.1371/journal.pone.0036774.g008
Figure 9. Rat Genome 230 2.0 Affymetrix chip analysis. RNA
purified from whole liver tissues of ten male and ten female rats was
hybridized to Rat Genome 230 2.0 Affymetrix chips. Gender-specific
differences in the expression of the HSD11B1, HMOX1, NQO1 and
ABCC3 genes were assessed. The data represent fold change in gene
expression (male vs. female). The statistical relevance was assessed by
multiple unpaired t-tests, with Benjamini Hochberg FDR multiple
testing correction, p#0.01.
doi:10.1371/journal.pone.0036774.g009
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mediated target gene regulation. Future work should include
animal experimentation and clinical studies to assess whether
pharmacological inhibition of 11b-HSD1 or GR antagonism may
improve Nrf2-dependent cell defense and whether such interven-
tion may be beneficial for ALD patients or for patients with
chronic inflammation such as diabetes or rheumatoid arthritis.
Materials and Methods
Materials
[1,2-3H]-cortisone was purchased from American Radiolabeled
Chemicals (St. Louis, MO), cell culture media from Invitrogen
(Carlsbad, CA), sulforaphane from Sigma-Aldrich (Buchs, Swizer-
land) and all other chemicals from Fluka AG (Buchs, Switzerland).
The luciferase reporter plasmid containing an eight times repeated
antioxidant response element (ARE8L-reporter), human Nrf2,
human recombinant GR-a and human 11b-HSD1 expression
constructs have been described earlier [21,43]. Human HEK-293
cells (No CRL-1573) and rat H4IIE hepatoma cells (No CRL-
1600) were obtained from ATCC through LGC Standards S.a.r.l.,
Molsheim Cedex, France. H4IIE cells stably expressing murine
11b-HSD1 (clone H4H1) were described earlier [24]. The work
was performed under the approval number A070126 from the
Eidgeno¨ssisches Departement fu¨r Umwelt, Verkehr, Energie und
Kommunikation UVEK, Bundesamt fu¨r Umwelt BAFU, Switzer-
land.
Cell culture and transfection
HEK-293 ells (100’000 cells/well) were cultured in Dulbecco’s
modified Eagle medium (DMEM) supplemented with 10% fetal
bovine serum, 4.5 g/L glucose, 50 U/mL penicillin/streptomycin,
2 mM glutamine, and 1 mM HEPES, pH 7.4, were seeded in
poly-L-lysine coated 24-well plates and incubated for 16 h. Cells
were transfected using calcium phosphate precipitation with
ARE8L-reporter (0.20 mg/well), pCMV-LacZ galactosidase trans-
fection control (0.03 mg/well), GR (0.20 mg/well), Nrf2 (0.20 mg/
well), and either 11b-HSD1 (0.20 mg/well) or empty pcDNA3
vector (0.20 mg/well).
H4IIE and H4H1 cells were cultured in antibiotic-free DMEM
supplemented as given above. H4IIE and H4H1 cells were
transfected using electroporation (NeonTM, Invitrogen) according
to the manufacturer. Cells were trypsinized, washed once with
PBS, centrifuged for 2 min at 1006g and resuspended in 288 mL
resuspension buffer with the final transfection density of 16106
cells/mL. Cells were subjected to a single pulse using a 100 mL
gold tip at 1375 V for 30 ms, with a total amount of 2.5 mg DNA
consisting of ARE8L-reporter (2 mg) and pCMV-LacZ galactosi-
dase transfection control (0.5 mg). To assess the impact of 11b-
HSD1, H4IIE cells were also transiently transfected with plasmids
for 11b-HSD1 (2 mg) or pcDNA3 control (2 mg), ARE8L-reporter
(2 mg) and pCMV-LacZ (0.5 mg).
To assess the susceptibility of H4IIE cells to H2O2-mediated
redox sensitivity, cells were transfected with either pcDNA3 (2 mg)
or 11b-HSD1 (2 mg) and 4 mg of the cytosolic HyPer-plasmid [44].
Cells (100’000 cells/well) were cultured in DMEM for 24 h at
37uC in six-well plates containing glass coverslips. Cells were
washed once with charcoal-treated, steroid-free DMEM
(DMEMct) and incubated for another 3 h. The culture medium
was replaced with fresh DMEMct containing cortisone (100 nM)
with or without 11b-HSD1 inhibitor T0504 (1 mM) [45] and cells
were cultured for another 24 h. To evaluate whether GR
transactivation is influenced by H2O2-mediated oxidative stress,
H4IIE cells were transfected with TAT3-TATA (2 mg) and
pCMV-LacZ transfection control (0.5 mg).
To further elaborate the role of basal 11b-HSD1 expression,
HPCT-1E3 cells endogenously expressing 11b-HSD1, were
cultured in DMEM supplemented with 10% fetal bovine serum,
4.5 g/L glucose, 50 U/mL penicillin/streptomycin, 1.5 mM
dexamethasone, 10 mg/mL insulin and inosine and 4 mM
glutamine (Dex-DMEM) [46].
Construction of H4IIE cells stably expressing the ARE8L-
reporter
H4IIE cells at passage four were co-transfected by electropora-
tion with the ARE8L-reporter plasmid and pcDNA3.1(+) contain-
ing a neomycin resistance gene. Transfected cells were screened
upon administration of 2 mg/mL G418 (Invitrogen, Carlsbad,
CA) over two weeks. Single clones stably expressing ARE8L were
selected from neomycin resistant H4IIE cells. Isolated single clones
were verified for their luciferase activity in transactivation assays
after stimulation with sulforaphane (10 mM) for 24 h at 37uC. Cell
clones expressing high levels of ARE8L were further sub-cultivated
for two weeks with DMEM containing 1 mg/mL G418 to
maintain selective pressure. The single clone designated as
ARECS3 was used for further experiments.
Nrf2 and GR transactivation assays
Cells were washed twice with DMEM 6 h post-transfection,
followed by incubation for 24 h at 37uC in antibiotic-free DMEM
to allow sufficient expression. Cells were washed once with steroid-
and serum-free DMEM (DMEMsf) and incubated for 3 h at 37uC.
For Nrf2 transactivation the culture medium was replaced with
fresh DMEMsf containing sulforaphane (10 mM), T0504 (1 mM),
RU-486 (1 mM) and combinations of them, in the presence or
absence of glucocorticoids (100 nM). For IC50 determination,
H4IIE cells were simultaneously treated with sulforaphane
(10 mM) and increasing concentrations of cortisol (4–972 nM).
The influence of oxidative stress on GR transactivation was
assessed in H4IIE cells treated with cortisol (100 nM), sulfor-
aphane (10 mM) and combinations of them, in the presence or
absence of H2O2 (2 mM). Activation of Nrf2 by H2O2-mediated
oxidative stress was assessed in ARECS3 cells stably expressing the
ARE8L reporter construct. Cells were treated with vehicle or
sulforaphane (10 mM) in the presence or absence of H2O2 (2 mM).
After incubation for another 24 h, cells were washed once with
PBS, lysed with 60 mL lysis buffer of the Tropix kit (Applied
Biosystems, Foster City, CA) supplemented with 0.5 mM dithio-
threitol, and frozen. Lysates were analyzed for luciferase activity
using a home-made luciferine-solution [14]. b-galactosidase
activity was analyzed using the Tropix kit according to the
manufacturer.
Analysis of mRNA expression by real-time RT-PCR
H4IIE and H4H1 cells (500’000 cells/well) were cultured in 24-
well plates with DMEM for 12 h at 37uC. Cells were washed once
with DMEMsf and incubated for another 3 h at 37uC. The culture
medium was replaced with fresh DMEMsf containing sulfora-
phane (10 mM), T0504 (1 mM), RU-486 (1 mM) or combinations
of them, in the presence or absence of glucocorticoids (100 nM),
followed by incubation for another 24 h at 37uC. The role of
endogenous 11b-HSD1 expression was assessed in HPCT-1E3
cells. HPCT-1E3 cells (1’000’000 cells/well) seeded in six-well
plates were cultivated for 12 h at 37uC in DMEM supplemented
with 1.5 mM dexamethasone. Cells were washed twice with
DMEMct and incubated for 3 h at 37uC. The culture medium
was replaced with fresh DMEMct and cells were cultivated for
another 24 h at 37uC. The influence of oxidative stress on 11b-
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HSD1 expression was assessed in HPCT-1E3 cells treated with
H2O2 (2 mM) for 24 h at 37uC. Total mRNA was extracted using
the Trizol method (Invitrogen, Carlsbad, CA). Total mRNA (2 mg)
was reverse transcribed to cDNA using the Superscript-III First-
Strand Synthesis System and oligo-dT (Invitrogen). Relative
quantification of mRNA expression levels was performed by
RT-PCR on a RotorGene 6000 (Corbett, Australia) using the
KAPA SYBRH FAST qPCR Kit (Kapasystems, Boston, MA).
Relative gene expression compared with the internal control
GAPDH was determined using the delta-delta-CT method.
Western blot analysis
H4IIE cell lysates (10 mg of protein) were obtained upon lysis in
RIPA buffer (25 mM Tris-HCl, pH 7.6, 150 mM NaCl, 1% NP-
40, 1% sodium deoxycholate, 0.1% SDS). Samples were resolved
by electrophoresis on a 12% polyacrylamide gel. Proteins were
transferred to nitrocellulose membranes, which were blocked
overnight at 4uC using 10% fat-free milk in TBS containing 0.1%
Tween-20. For NQO1 protein determination membranes were
probed for 1 h at 4uC with anti-NQO1 (1:2000; Abcam, ab2346)
and anti-actin (1:2000; santa-cruz, sc-1616) primary antibodies in
TBS containing 0.1% Tween-20 and 2% fat-free milk. For Nrf2
protein determination membranes were probed for 2 h at 4uC
with anti-Nrf2 rabbit polyclonal (1:2000; Abcam, ab53019) and
anti-actin (1:2000; santa-cruz, sc-1616) primary antibodies in TBS
containing 0.1% Tween-20 and 5% fat-free milk. Membranes
were washed 4615 min with TBS, 0.1% Tween-20 at 25uC and
then probed for 1 h at 4uC with anti-goat (1:2000, DAKO, p0449)
and anti-rabbit (1:2000, Sigma, A0545) HRP-linked secondary
antibodies in TBS containing 0.1% Tween-20 and 2% fat-free
milk. Membranes were washed 4615 min with TBS, 0.1%
Tween-20 and proteins were visualized by Enhanced Chemilu-
minescence plus (GE Healthcare) using a Fujifilm LAS-4000
detection system (Bucher Biotec, Basel, Switzerland).
Detection of H2O2 sensitivity by fluorescence microscopy
A Leica SP5 confocal microscope was used for single cell
imaging. Scanning was performed at 400 Hz in a 5126512 pixel
format. Excitation of the protonated and charged form of HyPer
[44] were performed using the 405 nm and the 488 nm laser lines,
respectively. Emission was recorded between 500–554 nm.
Pictures were taken every 20 s and 488/405 emission intensity
ratios calculated. For analyzing the total cell population, the
Gemini-EM spectrofluorometer (Molecular Devices, Sunnyvale,
CA) was used. Excitation of the protonated form of HyPer was
measured at 420 nm. Excitation of the charged form was detected
at 490 nm, and emission was recorded at 535 nm. Data were
recorded every 27 s over 9 h at 37uC.
Rat genome chip analysis
RNA purified from whole liver tissues of 20 Han Wistar rats
(animals listed in Table S1) were hybridized to Rat Genome 230
2.0 chips (Affymetrix, Santa Clara, CA) for characterization of
gene expression. Hybridization mixtures were prepared using the
39-IVT Express Kit (Affymetrix) to accommodate 10 mg of labeled
cDNA in 200 mL of hybridization mix. Rat Genome 230 2.0
Arrays were hybridized, revealed and washed according to the
Affymetrix protocol. GeneChips were scanned using the Affyme-
trix 3000 scanner and images were converted to files (*.cel). The
raw data were analyzed by GeneSpring GX 11.5.1 (Agilent) using
the software default settings for Affymetrix expression chips. Raw
data were pre-processed by Robust Multi-array Analysis (RMA)
algorithm (including Quantile normalization), Log transformed
(Table S2) and then pre-filtered within the 20–100 percentiles
assuming the median as baseline (raw data). Of the 31099 probe-
sets in Rat Genome 230 2.0 chip, 27359 have passed the pre-filter.
Correlation plot (not shown) shows the correlation analysis (heat
map, Pearson correlation factor) across arrays: high correlation
degree is indicative of good experimental execution and high
reproducibility. The internal quality controls of Affymetrix chips
showed no abnormalities in the hybridization processes (not
shown). Both analyses were part of the default quality controls
[47,48,49,50,51].
Supporting Information
Table S1 Han Wistar rats (disease status normal) used for RNA
purification of whole liver tissues (Rat Genome 230 2.0 Affymetrix
chip analysis).
(DOC)
Table S2 Raw and normalized gene expression data from
Affymetrix chips.
(DOC)
Figure S1 Increase of Nrf2 and NQO1 protein expres-
sion by proteasome inhibitor MG132 in H4IIE cells. To
see whether proteasome inhibition would increase Nrf2 protein
expression, as well as that of the transcriptionally regulated target
NQO1, we incubated H4IIE cells for 4 h with vehicle (0.05%
DMSO) or 10 mM of the proteasome inhibitor MG132 (upper
panel). Cells were lysed, and equal protein amounts were used for
Western blot analysis. Samples were probed for Nrf2 and NQO1,
using actin as a loading control. Lower panel, densitometric analysis
of Nrf2 (left) and NQO1 (right) protein normalized against b-actin.
MG132 increased Nrf2 and NQO1 protein approximately two-
fold. Graphs are representative of two independent experiments.
(TIF)
Figure S2 Sulforaphane does not inhibit 11b-HSD1
activity. Enzymatic activities were determined in intact H4H1
cells stably expressing 11b-HSD1. Briefly, 30,000 cells/well were
seeded in 96-well plates (Becton-Dickinson, Basel, Switzerland).
Cells were washed once 24 h later with 50 mL DMEMsf and
incubated for another 3 h at 37uC. The medium was replaced by
40 mL fresh medium containing either vehicle or sulforaphane,
and 10 mL medium containing 10 nCi [1,2-3H]-cortisone and
50 nM unlabeled cortisone to assess 11b-HSD1 reductase activity.
Cells were incubated for 40 min at 37uC and reactions stopped by
adding 2 mM of unlabeled cortisone and cortisol in methanol,
followed by separation of steroids by thin layer chromatography
and determination of the conversion of radiolabeled substrate by
scintillation counting. 11b-HSD1 activity after sulforaphane
treatment was indistinguishable from that of control cells treated
with vehicle (DMSO). Data represent mean 6 SD from at least
three independent experiments measured in triplicate. P-value was
determined using unpaired, two-tailed student t-test (ns, not
significant).
(TIF)
Figure S3 HSD11B1 mRNA expression and activity is
unaffected by H2O2. To assess whether HSD11B1 mRNA
expression is influenced by H2O2, HPCT-1E3 cells were cultivated
for 24 h at 37uC in the presence of vehicle (0.05% DMSO) or
H2O2 (2 mM) (A). Total mRNA was extracted using the Trizol
method (Invitrogen, Carlsbad, CA). Total mRNA (2 mg) was
reverse transcribed to cDNA using the Superscript-III First-Strand
Synthesis System and oligo-dT (Invitrogen). Relative quantifica-
tion of HSD11B1 mRNA expression was performed by RT-PCR
on a RotorGene 6000 (Corbett, Australia) using the KAPA
SYBRH FAST qPCR Kit (Kapasystems, Boston, MA). Relative
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HSD11B1 gene expression compared with the internal control
GAPDH was determined using the delta-delta-CT method. Data
(mean 6 SD from two independent experiments measured in
triplicate) represent ratios of 11ß-HSD1 mRNA to GAPDH
control mRNA from treated cells normalized to the values
obtained from cells incubated with vehicle (DMSO). Enzymatic
activities were determined in intact HPTC-1E3 cells expressing
endogenous 11b-HSD1 that were treated with vehicle (DMSO),
2 mM H2O2 (B) or 1 mM RU-486 (C). Briefly, 50’000 cells/well
were seeded in 96-well plates (Becton-Dickinson, Basel, Switzer-
land). Cells were washed twice 12 h later with 50 mL DMEMct
and incubated for another 24 h at 37uC. The medium was
replaced by 40 mL fresh medium containing either vehicle, H2O2
(2 mM) or RU-486 (1 mM), and 10 mL medium containing 10 nCi
[1,2-3H]-cortisone and 50 nM unlabeled cortisone to assess 11b-
HSD1 reductase activity. Cells were incubated for 4 h at 37uC and
reactions stopped by adding 2 mM of unlabeled cortisone and
cortisol in methanol, followed by separation of steroids by thin
layer chromatography and determination of the conversion of
radiolabeled substrate by scintillation counting. Oxidative stress
induced by H2O2 neither changed the expression of 11b-HSD1
mRNA nor its activity in HPCT-1E3 cells. Furthermore, the GR
inhibitor RU-486 did not affect 11b-HSD1 activity. Data
represent mean 6 SD from three independent experiments.
(TIF)
Figure S4 The 11b-HSD1 inhibitor T0504 restores
NQO1 mRNA and GST2A mRNA expression in H4H1
cells. H4H1 cells (500’000 cells/well) were cultured in 24-well
plates with DMEM for 12 h at 37uC. Cells were washed once with
DMEMsf and incubated for another 3 h at 37uC. The culture
medium was replaced with fresh DMEMsf containing sulfora-
phane (10 mM), T0504 (1 mM) or combinations of them, in the
presence or absence of cortisone (100 nM), followed by incubation
for 24 h at 37uC. Total mRNA was extracted using the Trizol
method (Invitrogen, Carlsbad, CA). Total mRNA (2 mg) was
reverse transcribed to cDNA using the Superscript-III First-Strand
Synthesis System and oligo-dT (Invitrogen). Relative quantifica-
tion of mRNA expression levels was performed by RT-PCR on
a RotorGene 6000 (Corbett, Australia) using the KAPA SYBRH
FAST qPCR Kit (Kapasystems, Boston, MA). Relative gene
expression compared with the internal control GAPDH was
determined using the delta-delta-CT method. Incubation with
cortisone (100 nM) suppressed basal (0.5-fold and 0.3-fold) as well
as sulforaphane-induced (1.5-fold and 2-fold) NQO1 (A) and
GST2A mRNA (B) expression in H4H1 cells. Simultaneous
treatment with the 11b-HSD1 inhibitor T0504 restored NQO1
and GST2A mRNA expression and fold activation was almost
indistinguishable from cells treated with sulforaphane alone (2-fold
and 2.8-fold) or vehicle control expression levels. Data represent
mean 6 SD from a representative experiment measured in
triplicate.
(TIF)
Figure S5 Incubation with cortisone suppresses NQO1
and GST2A mRNA expression in HPCT-1E3 cells with
endogenous 11b-HSD1 activity. HPCT-1E3 cells (1’000’000
cells/well) were cultured in 6-well plates with dexamethasone
supplemented DMEM for 12 h at 37uC. Cells were washed twice
with DMEMct and incubated for another 3 h at 37uC. The
culture medium was replaced with fresh DMEMct and cells were
cultivated for another 24 h at 37uC. To assess whether basal 11b-
HSD1 activity suppresses Nrf2, the culture medium was replaced
with fresh DMEMct containing vehicle, sulforaphane (10 mM),
T0504 (1 mM), and combinations of them, in the presence or
absence of cortisone (100 nM) and cells were incubated for
another 24 h at 37uC. Total mRNA was extracted using the Trizol
method (Invitrogen, Carlsbad, CA). Total mRNA (2 mg) was
reverse transcribed to cDNA using the Superscript-III First-Strand
Synthesis System and oligo-dT (Invitrogen). Relative quantifica-
tion of Nrf2 mRNA expression was performed by RT-PCR on
a RotorGene 6000 (Corbett, Australia) using the KAPA SYBRH
FAST qPCR Kit (Kapasystems, Boston, MA). Relative NQO1
mRNA and GST2A mRNA gene expression compared with the
internal control GAPDH was determined using the delta-delta-CT
method. NQO1 (A) and GST2A (B) mRNA expression levels were
induced by sulforaphane (10 mM) 4-fold and 14-fold, respectively,
in HPCT-1E3 cells. Cortisone (100 nM) treatment reduced both
NQO1 and GST2A mRNA expression levels. Data represent
mean 6 SD from a representative (one out of three) experiment
performed in triplicate.
(TIF)
Figure S6 Expression of the Nrf2-dependent genes
NQO1, Abcc3 and Hmox1 in comparison to HSD11B1
relative expression. HSD11B1 relative gene expression was
evaluated in comparison to NQO1, Abcc3 and Hmox1, in each
animal, by scatter plot. RNA purified from whole liver tissues of 20
Han Wistar rats (animals listed in Table S1) were hybridized to
Rat Genome 230 2.0 chips (Affymetrix, Santa Clara, CA) for
characterization of gene expression. Hybridization mixtures were
prepared using the 39-IVT Express Kit (Affymetrix) to accommo-
date 10 mg of labeled cDNA in 200 mL of hybridization mix. Rat
Genome 230 2.0 Arrays were hybridized, revealed and washed
according to the Affymetrix protocol. GeneChips were scanned
using the Affymetrix 3000 scanner and images were converted to
files (*.cel). The raw data were analyzed by GeneSpring GX 11.5.1
(Agilent) using the software default settings for Affymetrix
expression chips (Table S2). Raw data were pre-processed by
Robust Multi-array Analysis (RMA) algorithm (including Quantile
normalization), Log transformed and then pre-filtered within the
20–100 percentile assuming the median as baseline (raw data). Of
the 31099 probe-sets in Rat Genome 230 2.0 chip, 27359 have
passed the pre-filter. Correlation plot (not shown) shows the
correlation analysis (heat map, Pearson correlation factor) across
arrays: high correlation degree is indicative of good experimental
execution and high reproducibility. The internal quality controls
of Affymetrix chips showed no abnormalities in the hybridization
processes (not shown). Both analyses were part of the default
quality controls. Linear regression analysis was used to obtain the
overall correlation (R2) of HSD11B1 expression with other genes
(HSD11B1 vs. Nqo1 R2= 0.546, p value = 2.00E-004; HSD11B1
vs. Abcc3 R2= 0.407, p value = 2.47E-003; HSD11B1 vs. Hmox1
R2= 0.692, p value = 5.38E-006). The statistical relevance was
assessed by multiple unpaired t-tests, with Benjamini Hochberg
FDR multiple testing correction, p#0.05.
(TIF)
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